Multiple Sclerosis (MS) - Multiple Sclerosis (MS) - The Merck …
WEBMay 9, 2023 · Multiple sclerosis (MS) is characterized by disseminated patches of demyelination in the brain and spinal cord. Common symptoms include visual and oculomotor abnormalities, paresthesias, weakness, spasticity, urinary dysfunction, and mild cognitive symptoms.
Multiple Sclerosis - Expertise - Merck
WEBMultiple Sclerosis. We aim to improve the lives of those living with MS, having spent over 20 years researching and developing solutions for advancing MS care. Our aim is to address areas of unmet medical needs.
Merck Neurology Hub
WEBMerck Neurology Hub Committed to transforming MS care. Discover the latest Merck innovations in Multiple Sclerosis, and find out about real-world experience with our MS treatments.
Merck Provides Update on Phase III Results for Evobrutinib in …
WEBDec 5, 2023 · Merck has a long-standing legacy in neurology and immunology, with significant R&D and commercial experience in multiple sclerosis (MS). The company’s current MS portfolio includes two...
Multiple Sclerosis Treatments - Expertise - Merck
WEBMerck ideas are everywhere – they can be life-changing, influencing how we tackle major illness, or be integral to the objects we rely on every day. Read more
ABOUT MERCK IN MS - Merck Neurology
WEBABOUT MERCK IN MS. COMMITMENT TO MS. Merck has over 20 years of experience in multiple sclerosis (MS) care and remains committed to finding solutions for patients’ unmet medical needs by advancing MS care.
Multiple Sclerosis (MS) - Multiple Sclerosis (MS) - The Merck …
WEBMultiple Sclerosis (MS) - Learn about the causes, symptoms, diagnosis & treatment from the Merck Manuals - Medical Consumer Version.
Multiple Sclerosis (MS) - The Merck Manuals
WEBWhat is multiple sclerosis (MS)? | What causes MS? | What are the symptoms of MS? | How can doctors tell if I have MS? | How do doctors treat MS? | Where can I find more information on MS? |
Advances in MS Portfolio - Merck
WEBMar 31, 2022 · Merck has a long-standing legacy in neurology and immunology, with significant R&D and commercial experience in multiple sclerosis (MS). The company`s current MS portfolio includes two products for the treatment of relapsing MS – Rebif® (interferon beta-1a) and MAVENCLAD® (cladribine tablets).
Home - MS Inside Out
WEBUnderstanding MS. If you have been impacted by Multiple Sclerosis (MS), this website can help you to understand the causes of MS, signs and symptoms, and what’s next after diagnosis.
Skip to content